Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer's disease
© 2022. The Author(s)..
Myeloid cells are suggested as an important player in Alzheimer´s disease (AD). However, its continuum of phenotypic and functional changes across different body compartments and their use as a biomarker in AD remains elusive. Here, we perform multiple state-of-the-art analyses to phenotypically and metabolically characterize immune cells between peripheral blood (n = 117), cerebrospinal fluid (CSF, n = 117), choroid plexus (CP, n = 13) and brain parenchyma (n = 13). We find that CSF cells increase expression of markers involved in inflammation, phagocytosis, and metabolism. Changes in phenotype of myeloid cells from AD patients are more pronounced in CP and brain parenchyma and upon in vitro stimulation, suggesting that AD-myeloid cells are more vulnerable to environmental changes. Our findings underscore the importance of myeloid cells in AD and the detailed characterization across body compartments may serve as a resource for future studies focusing on the assessment of these cells as biomarkers in AD.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Nature communications - 13(2022), 1 vom: 23. Nov., Seite 7210 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Fernández Zapata, Camila [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 25.11.2022 Date Revised 28.12.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41467-022-34719-2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM349314012 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM349314012 | ||
003 | DE-627 | ||
005 | 20231226042325.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41467-022-34719-2 |2 doi | |
028 | 5 | 2 | |a pubmed24n1164.xml |
035 | |a (DE-627)NLM349314012 | ||
035 | |a (NLM)36418303 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Fernández Zapata, Camila |e verfasserin |4 aut | |
245 | 1 | 0 | |a Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer's disease |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.11.2022 | ||
500 | |a Date Revised 28.12.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s). | ||
520 | |a Myeloid cells are suggested as an important player in Alzheimer´s disease (AD). However, its continuum of phenotypic and functional changes across different body compartments and their use as a biomarker in AD remains elusive. Here, we perform multiple state-of-the-art analyses to phenotypically and metabolically characterize immune cells between peripheral blood (n = 117), cerebrospinal fluid (CSF, n = 117), choroid plexus (CP, n = 13) and brain parenchyma (n = 13). We find that CSF cells increase expression of markers involved in inflammation, phagocytosis, and metabolism. Changes in phenotype of myeloid cells from AD patients are more pronounced in CP and brain parenchyma and upon in vitro stimulation, suggesting that AD-myeloid cells are more vulnerable to environmental changes. Our findings underscore the importance of myeloid cells in AD and the detailed characterization across body compartments may serve as a resource for future studies focusing on the assessment of these cells as biomarkers in AD | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Biomarkers |2 NLM | |
700 | 1 | |a Giacomello, Ginevra |e verfasserin |4 aut | |
700 | 1 | |a Spruth, Eike J |e verfasserin |4 aut | |
700 | 1 | |a Middeldorp, Jinte |e verfasserin |4 aut | |
700 | 1 | |a Gallaccio, Gerardina |e verfasserin |4 aut | |
700 | 1 | |a Dehlinger, Adeline |e verfasserin |4 aut | |
700 | 1 | |a Dames, Claudia |e verfasserin |4 aut | |
700 | 1 | |a Leman, Julia K H |e verfasserin |4 aut | |
700 | 1 | |a van Dijk, Roland E |e verfasserin |4 aut | |
700 | 1 | |a Meisel, Andreas |e verfasserin |4 aut | |
700 | 1 | |a Schlickeiser, Stephan |e verfasserin |4 aut | |
700 | 1 | |a Kunkel, Desiree |e verfasserin |4 aut | |
700 | 1 | |a Hol, Elly M |e verfasserin |4 aut | |
700 | 1 | |a Paul, Friedemann |e verfasserin |4 aut | |
700 | 1 | |a Parr, Maria Kristina |e verfasserin |4 aut | |
700 | 1 | |a Priller, Josef |e verfasserin |4 aut | |
700 | 1 | |a Böttcher, Chotima |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 13(2022), 1 vom: 23. Nov., Seite 7210 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2022 |g number:1 |g day:23 |g month:11 |g pages:7210 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-022-34719-2 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2022 |e 1 |b 23 |c 11 |h 7210 |